Author | Marcia S. Brose, MD, PhD | OncLive

Author | Marcia S. Brose, MD, PhD

Articles

Dr. Marcia Brose Discusses Lenvatinib as a New Option in DTC

February 13, 2015

Video

Marcia S. Brose, MD, PhD, associate professor of Otorhinolaryngology: Head and Neck Surgery at the Hospital of the University of Pennsylvania, discusses lenvatinib as a new treatment option for patients with radioactive iodine-refractory differentiated thyroid cancer.

Dr. Brose Discusses Lenvatinib and Sorafenib in Differentiated Thyroid Cancer

November 02, 2014

Video

Marcia S. Brose, MD, PhD, assistant professor, Abramson Cancer Center at the University of Pennsylvania, discusses the rapidly changing treatment landscape for patients with differentiated thyroid cancer.

Dr. Brose on the FACT2 Study and the Treatment of ATC

January 24, 2014

Video

Marcia S. Brose, MD, PhD, from the University of Pennsylvania, discusses the treatment of anaplastic thyroid cancer (ATC) and the FACT2 study.

Dr. Brose Describes the DECISION Trial

December 03, 2013

Video

Marcia S. Brose, MD, PhD, assistant professor, Abramson Cancer Center, Department of Otolaryngology, Head & Neck Surgery, Department of Medicine, Division of Hematology/Oncology, Department of Dermatology, University of Pennsylvania, describes the DECISION trial, which analyzed the efficacy of sorafenib in differentiated thyroid cancer.

x